Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
COVID Symptoms |
Schedule a COVID vaccine or booster appointment:
Log in to myPennMedicine or call us 8am to 5pm, Monday through Friday, at 267-758-4902.
There is no publicly available rating for this medical professional for one of the following reasons:
Sees patients age 18 and up
Sees patients age 18 and up
Razis E, Kassapian M, Andriakopoulou C, Martei YM, Zurn SJ, Hammad N, Romero Y, Dafni U, Ilbawi AM, Trapani D.: Essential medicines list in national cancer control plans: a secondary analysis from a global study. The Lancet Oncology 23 (3): e144-154,2022.
Martei YM, Rick TJ, Fadelu T, Ezzi MS, Hammad N, Quadri NS, Rodrigues B, Simonds H, Grover S, Incrocci L, Vanderpuye V.: Impact of COVID-19 on Cancer Care Delivery in Africa: A Cross-Sectional Survey of Oncology Providers in Africa. JCO Glob Oncol 7 : 368-377,2021.
Ralefala T, Mokokwe L, Jammalamadugu S, Legobere D, Motlhwa WS, Oyekunle AA, Grover S, Barg FK, Shulman LN, Martei YM: Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis Oncologist 25 : 1-9,2021.
Martei YM, Zürn SJ: Addressing antimicrobial resistance for better care in cancer patients Global Antibiotic Research & Development Partnership : 2021.
Davey S, Grover S, Bilker WB, Setlhako DI, Ralefala TB, Manshimba P, Gross R, DeMichele A, Shulman LN, Martei YM.: Retrospective cohort analysis of prescription patterns of cancer medications during periods of drug stockouts in Botswana. BMJ Open 12 (11): 2021.
LeJeune A, Brock JE, Morgan EA, Kasten JL, Martei YM, Fadelu T, Rinder HM, Goulart R, Shulman LN, Milner DA Jr.: Harmonization of the Essentials: Matching Diagnostics to Treatments for Global Oncology. JCO Global Oncology 6 : 2020.
Martei YM, Iwamoto K, Barr RD, Wiernkowski JT, Robertson J.: Shortages and Price Variability of Essential Cytotoxic Medicines for Treating Children with Cancers BMJ Global Health In Press : 2020.
Martei YM, Grover S, Narasimhamurthy M, Setlhako DI, Ayane GN, Ralefala TB, Chiyapo SP, Gross R, DeMichele A, Shulman LN: Relative dose intensity and pathologic response rates in HIV-infected and HIV-uninfected breast cancer patients who received neoadjuvant chemotherapy. Journal of Clinical Oncology 18 (15 Suppl e19140): 2020.
Martei YM, Grover S, Bilker WB, Monare B, Setlhako DI, Ralefala TB, Manshimba P, Gross R, Shulman LN, DeMichele A.: Impact of Essential Medicine Stock Outs on Cancer Therapy Delivery in a Resource-Limited Setting. J Glob Oncol. 5 : 1-11,2019.
Bhatia RK, Narasimhamurthy M, Martei YM, Prabhakar P, Hutson J, Chiyapo S, Makozhombwe I, Feldman M, Kayembe MKA, Cooper K, Grover S.: Report of clinico-pathological features of breast cancer in HIV-infected and uninfected women in Botswana. Infectious Agents and Cancer 14 (28): 2019.
3400 Civic Center Blvd.